Acute T cell-mediated rejection after administration of the BNT162b2 mRNA COVID-19 vaccine in a kidney transplant recipient without a history of acute rejection for 13 years: a case report | Zendy

AI Assistant Blog Pricing

Acute T cell-mediated rejection after administration of the BNT162b2 mRNA COVID-19 vaccine in a kidney transplant recipient without a history of acute rejection for 13 years: a case report

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.